Renowned Spanish distributor and provider of high value-added In-Vitro Diagnostics equipment, solutions and services for public and private hospitals and laboratories.
Partnering with the founder and an ambitious management team to consolidate the Company’s positioning as leading provider of advanced In Vitro Diagnostic (IVD) solutions and services in Spain, active in high-growth therapeutic areas and supported by a diversified portfolio of innovative technologies. Growth will be driven by targeted organic and inorganic initiatives, leveraging the Company’s established expertise in Next-Generation Sequencing (NGS) technology and further accelerated by a selective international M&A strategy, to create the leading high–value-added niche distribution platform in Southern Europe for advanced IVD solutions.
Changing Life/Consumer Behaviors; Ageing & Diversified Demographics; Technological Acceleration
Spain
Healthcare
Our manifesto: contributing to the development of sustainable finance
To succeed with this strategy, Apheon believes a holistic and collective approach is fundamental.
Holistic: it is essential that all aspects of ESG are equally and continuously supported. This is why we are active at every stage of the investment cycle by applying proprietarily developed methodologies and initiatives which are built on 5 priorities covering the broad ESG spectrum: